121 related articles for article (PubMed ID: 27754988)
21. Syncope of a drug addict - a special case.
Chatterjee B; Bürgi U
Clin Res Cardiol; 2006 Oct; 95(10):557-9. PubMed ID: 16865634
[No Abstract] [Full Text] [Related]
22. Methadone and torsade de pointes: case report and review of the literature.
Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
[TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
Nair MK; Patel K; Starer PJ
Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
[TBL] [Abstract][Full Text] [Related]
24. Methadone-induced torsade de pointes.
Nordt SP; Zilberstein J; Gold B
Am J Emerg Med; 2011 May; 29(4):476.e1-2. PubMed ID: 20674223
[No Abstract] [Full Text] [Related]
25. Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy.
NoorZurani MH; Vicknasingam B; Narayanan S
Drug Alcohol Rev; 2009 Nov; 28(6):688-90. PubMed ID: 19930027
[TBL] [Abstract][Full Text] [Related]
26. Torsades de pointes therapy with phenytoin.
Vukmir RB; Stein KL
Ann Emerg Med; 1991 Feb; 20(2):198-200. PubMed ID: 1996806
[TBL] [Abstract][Full Text] [Related]
27. Methadone-induced Torsades de pointes.
Russell L; Levine D
R I Med J (2013); 2013 Jul; 96(8):20-1. PubMed ID: 23923121
[TBL] [Abstract][Full Text] [Related]
28. [Not Available].
Krieg B
Med Monatsschr Pharm; 2016 Nov; 39(11):497-8. PubMed ID: 29956532
[No Abstract] [Full Text] [Related]
29. Summaries for patients. QTc interval screening in methadone treatment.
Ann Intern Med; 2009 Mar; 150(6):I-26. PubMed ID: 19153407
[No Abstract] [Full Text] [Related]
30. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
Bart G
Ann Intern Med; 2009 Aug; 151(3):218; author reply 218-9. PubMed ID: 19652193
[No Abstract] [Full Text] [Related]
31. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
Girgis G
Ann Intern Med; 2009 Aug; 151(3):217-8; author reply 218-9. PubMed ID: 19652192
[No Abstract] [Full Text] [Related]
32. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
Byrne A
Ann Intern Med; 2009 Aug; 151(3):216; author reply 218-9. PubMed ID: 19652191
[No Abstract] [Full Text] [Related]
33. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
Cohen SP; Mao J
Ann Intern Med; 2009 Aug; 151(3):216-7; author reply 218-9. PubMed ID: 19652190
[No Abstract] [Full Text] [Related]
34. [Torsades de pointes during methadone treatment].
Sánchez Hernández AM; Atienza Fernández F; Arenal Maíz A; González Torrecilla E; Puchol Calderón A; Almendral Garrote J
Rev Esp Cardiol; 2005 Oct; 58(10):1230-2. PubMed ID: 16238992
[TBL] [Abstract][Full Text] [Related]
35. Cocaine-related torsade de pointes in a methadone maintenance patient.
Krantz MJ; Rowan SB; Mehler PS
J Addict Dis; 2005; 24(1):53-60. PubMed ID: 15774410
[TBL] [Abstract][Full Text] [Related]
36. First, do no harm: QT interval screening in methadone maintenance treatment.
Haigney MC
J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
[No Abstract] [Full Text] [Related]
37. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.
Justo D
Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953
[No Abstract] [Full Text] [Related]
38. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
39. [Life-threatening, recurrent arrhythmia in patients on high-dose methadone treatment: torsade de pointes].
Al-Shakarshi JS; Bent-Hansen L; Jensen GB
Ugeskr Laeger; 2004 Aug; 166(36):3104-5. PubMed ID: 15387312
[No Abstract] [Full Text] [Related]
40. First do no harm ... Reduction?
Gourevitch MN
Ann Intern Med; 2009 Mar; 150(6):417-8. PubMed ID: 19225161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
